CADM3
Basic information
Region (hg38): 1:159171609-159203313
Previous symbols: [ "IGSF4B" ]
Links
Phenotypes
GenCC
Source:
- Charcot-Marie-Tooth disease, axonal, type 2FF (Limited), mode of inheritance: AD
- Charcot-Marie-Tooth disease, axonal, type 2FF (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Charcot-Marie-Tooth disease, axonal, type 2FF | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 33889941 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CADM3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 24 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 1 | 25 | 1 | 0 |
Variants in CADM3
This is a list of pathogenic ClinVar variants found in the CADM3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-159171815-G-A | Inborn genetic diseases | Uncertain significance (Dec 26, 2023) | ||
1-159171838-A-C | Inborn genetic diseases | Uncertain significance (Feb 28, 2024) | ||
1-159191945-C-T | Inborn genetic diseases | Uncertain significance (Feb 27, 2023) | ||
1-159191947-T-C | Inborn genetic diseases | Uncertain significance (Dec 28, 2023) | ||
1-159191983-G-A | Inborn genetic diseases | Uncertain significance (Apr 13, 2022) | ||
1-159192007-G-A | Inborn genetic diseases | Uncertain significance (Jan 03, 2024) | ||
1-159192042-T-G | Likely benign (Feb 01, 2023) | |||
1-159192608-C-T | Inborn genetic diseases | Uncertain significance (Dec 03, 2021) | ||
1-159192614-C-T | Inborn genetic diseases | Uncertain significance (Feb 27, 2023) | ||
1-159192718-G-A | Inborn genetic diseases | Uncertain significance (Jan 02, 2024) | ||
1-159192730-G-C | Malignant tumor of prostate | Uncertain significance (-) | ||
1-159193421-AG-A | Charcot-Marie-Tooth disease, axonal, type 2FF | Uncertain significance (Oct 26, 2022) | ||
1-159193453-A-G | Charcot-Marie-Tooth disease, axonal, type 2FF | Likely pathogenic (Mar 29, 2024) | ||
1-159193458-T-C | Inborn genetic diseases | Uncertain significance (May 18, 2023) | ||
1-159193467-C-T | Inborn genetic diseases | Uncertain significance (May 17, 2023) | ||
1-159193507-G-A | Inborn genetic diseases | Uncertain significance (Jun 06, 2023) | ||
1-159193872-G-A | Inborn genetic diseases | Uncertain significance (Sep 01, 2021) | ||
1-159193944-A-G | Inborn genetic diseases | Uncertain significance (Jul 05, 2023) | ||
1-159193968-A-G | Inborn genetic diseases | Uncertain significance (Dec 17, 2023) | ||
1-159193971-G-A | Inborn genetic diseases | Uncertain significance (Jun 18, 2021) | ||
1-159196392-C-A | Inborn genetic diseases | Uncertain significance (Jun 27, 2022) | ||
1-159196401-T-A | Inborn genetic diseases | Uncertain significance (Feb 28, 2023) | ||
1-159196406-G-A | Inborn genetic diseases | Uncertain significance (Sep 25, 2023) | ||
1-159199789-G-A | Inborn genetic diseases | Uncertain significance (Feb 28, 2023) | ||
1-159199798-G-T | Charcot-Marie-Tooth disease, axonal, type 2FF | Uncertain significance (Apr 10, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CADM3 | protein_coding | protein_coding | ENST00000368124 | 10 | 31705 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.934 | 0.0661 | 125739 | 0 | 5 | 125744 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.69 | 168 | 242 | 0.694 | 0.0000137 | 2789 |
Missense in Polyphen | 42 | 81.713 | 0.514 | 928 | ||
Synonymous | 0.0532 | 99 | 99.7 | 0.993 | 0.00000631 | 867 |
Loss of Function | 3.74 | 3 | 21.9 | 0.137 | 0.00000115 | 241 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000556 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000278 | 0.0000264 |
Middle Eastern | 0.0000556 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the cell-cell adhesion. Has both calcium- independent homophilic cell-cell adhesion activity and calcium- independent heterophilic cell-cell adhesion activity with IGSF4, NECTIN1 and NECTIN3. Interaction with EPB41L1 may regulate structure or function of cell-cell junctions (By similarity). {ECO:0000250}.;
- Pathway
- Cell adhesion molecules (CAMs) - Homo sapiens (human);Splicing factor NOVA regulated synaptic proteins;Cell-cell junction organization;Nectin/Necl trans heterodimerization;Adherens junctions interactions;Cell junction organization;Cell-Cell communication
(Consensus)
Recessive Scores
- pRec
- 0.459
Intolerance Scores
- loftool
- rvis_EVS
- -0.49
- rvis_percentile_EVS
- 22.36
Haploinsufficiency Scores
- pHI
- 0.235
- hipred
- Y
- hipred_score
- 0.685
- ghis
- 0.679
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.468
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cadm3
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- homophilic cell adhesion via plasma membrane adhesion molecules;heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules;protein localization;adherens junction organization
- Cellular component
- plasma membrane;cell-cell junction;parallel fiber to Purkinje cell synapse;integral component of presynaptic membrane
- Molecular function
- protein homodimerization activity